Anemia in diabetes: Experience of a single treatment center in Kuwait

Alsayegh, Faisal; Waheedi, Mohammad; Bayoud, Tania; Hubail, Asma Al; Al-Refaei, Faisal; Sharma, Prem M.

doi:10.1016/j.pcd.2017.04.002

Cited by 16 publications

(12 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We found that diabetic females were at higher risk of anemia than diabetic males. This finding is consistent with the findings of Alsayegh et al (2017) which reported prevalence as 35.8% vs. 21.3% in diabetic females versus diabetic males [21]. The possible reason for higher prevalence of anemia in females might be due to poor nutrition, less importance given to their own health due to lack of empowerment.…”

Section: Discussionsupporting

confidence: 92%

Prevalence of Anemia in Type 2 Diabetic Patients

AlDallal

Jena

2018

J Hematol

View full text Add to dashboard Cite

Background: The aim of the study was to determine the prevalence of anemia in patients with type 2 diabetes and to assess the risk of anemia according to gender, age and glycemic control. Methods: The study group comprised of patients with type 2 diabetes attending Outpatient Diabetic Department of Amiri Hospital (Al-Asimah Capital area) from January 1, 2016 to December 31, 2017. Patients were divided into groups according to glycemic status and gender. Glycated hemoglobin (HbA1C) values and hemoglobin (Hb) levels were evaluated. The presence of anemia was defined by an Hb level < 13.0 g/dL for men and < 12.0 g/dL for women. Results: The prevalence of anemia is significantly greater in diabetic females (38.5%) than in diabetic males (21.6%) and in poorly controlled diabetics (33.46%) than those with glycemic status under control (27.9%) (P < 0.05). The average age of patients with anemia was found to be 60.69 ± 0.198 years and the average age of patients without anemia was found to be 54.07 ± 0.121 years. This indicates that the risk of anemia increases with age. Conclusion: Screening for anemia at the time of diagnosis of diabetes, diabetic medication compliance, awareness of the risk of anemia and other complications in the diabetic patients helps in reducing the prevalence of anemia in diabetic population.

show abstract

Section: Discussionsupporting

confidence: 92%

Prevalence of Anemia in Type 2 Diabetic Patients

AlDallal

Jena

2018

J Hematol

View full text Add to dashboard Cite

show abstract

“…Renal impairment leads to anemia though impaired production of erythropoietin by peritubular fibroblast of the kidney, [65][66][67] urinary erythropoietin losses, 68 reduced RBC life span due to uremic environment and the possible role of circulating uremic-induced prevention of erythropoiesis. 69,70 40% 44% However, this study deviates from another study conducted in India, which showed a higher rate of the microcytic hypochromic type of anemia. 71 The low prevalence of microcytic hypochromic anemia in this study could be explained by their residence and access to health care services.…”

Section: Discussioncontrasting

confidence: 88%

<p>Anemia and Its Associated Factors Among Type 2 Diabetes Mellitus Patients Attending Debre Berhan Referral Hospital, North-East Ethiopia: A Cross-Sectional Study</p>

Taderegew¹,

Gebremariam²,

Tareke³

et al. 2020

JBM

View full text Add to dashboard Cite

Purpose: Anemia is one of the common complications of diabetes mellitus (DM), which has an adverse effect on the progression and development of other diabetes-related complications. In spite of this, relatively little information is available on the prevalence of anemia and associated factors among type 2 diabetes mellitus (T2DM) patients in Ethiopia, particularly in the study area. Thus, this study assessed the prevalence of anemia and associated factors among T2DM patients at Debre Berhan Referral Hospital (DBRH), NorthEast , Ethiopia. Patients and Methods: A hospital-based cross-sectional study was conducted from April 1 to May 30, 2019, among 249 T2DM patients with follow up at DBRH, selected using a systematic random sampling technique. Data were collected by face-to-face interviews, anthropometric measurements, and laboratory tests; such as hemoglobin measurements, red blood indices, and serum creatinine analysis. The data were coded and entered into Epi-data manager version 4.4.1.0, and analysis by using SPSS version 22 was carried out. To identify the determinant factors of anemia, bivariate and multivariate logistic regression analyses were performed. P-value <0.05 was considered as statistically significant. Results: The study showed 20.1% of the participants were anemic. Being age >60 years (AOR=3.06, 95% CI: 1.32-7.11), poor glycemic control (AOR=2.95, 95% CI: 1.22-7.15), eGFR 60-89.9 mL/min/1.73m 2 (AOR=2.91, 95% CI: 1.15-7.37), eGFR <60 mL/min/1.73m 2 (AOR=6.58, 95% CI: 2.42-17.93), DM duration >10 years (AOR= AOR=2.75, 95% CI: 1.17-6.48), and having diabetic complications (AOR=3.81, 95% CI: 1.65-8.81) were significantly associated with anemia. Conclusion: One out of five T2DM patients had anemia. Poor glycemic control, decreased eGFR, presence of DM complications, duration of DM >10 years, and age >60 years were significantly associated with the occurrence of anemia among T2DM. Regular screening for anemia in all T2DM patients may help in the early detection and management of anemia.

show abstract

“…Similar to our study, AlDallal et al [37] found that females with T2DM are at higher risk of anemia than males. This is consistent with findings of Alsayegh et al which reported a prevalence of 35.8% in females versus 21.3% in males [49].…”

Section: Discussionsupporting

confidence: 93%

Clinical Predictors of Iron Deficiency Anemia in Emirati Population with T2DM

Nada¹,

Younan²

2021

OJBD

View full text Add to dashboard Cite

Aim: To establish the prevalence of iron deficiency anemia and its clinical predictors in Emirati patients with type 2 diabetes. Patients & Methods: 237 patients were included in the study. A full blood count was obtained in addition to routine blood and urine tests for all patients. Hemoglobin level and iron studies were done for diagnosis of anemia. Statistical analysis was done to find out the prevalence and independent predictors of anemia in the study population of Emirati type 2 diabetic patients. Results: Of the studied 237 patients; 36.3% had iron deficiency anemia as per the WHO criteria. Independent predictors of iron deficiency anemia were age ≥ 60 years, female gender and wide pulse pressure ≥ 60 mmHg. Hemoglobin level was directly proportionate to e GFR (p < 0.001). Participants with age ≥ 60 years had 4.2 times higher odds to exhibit anemia. Female participants had 1.95 times higher odds to exhibit anemia. Participants with wide pulse pressure ≥ 60 mmHg have 2.4 higher odds to exhibit anemia. Conclusion: Iron deficiency anemia is common in type 2 diabetic patients. Testing the patient for iron deficiency anemia should be considered in type 2 diabetes patients especially with age ≥ 60 years, female patients and those with wide pulse pressure ≥ 60 mmHg.

show abstract

Anemia in diabetes: Experience of a single treatment center in Kuwait

Cited by 16 publications

References 27 publications

Prevalence of Anemia in Type 2 Diabetic Patients

Prevalence of Anemia in Type 2 Diabetic Patients

<p>Anemia and Its Associated Factors Among Type 2 Diabetes Mellitus Patients Attending Debre Berhan Referral Hospital, North-East Ethiopia: A Cross-Sectional Study</p>

Clinical Predictors of Iron Deficiency Anemia in Emirati Population with T2DM

Contact Info

Product

Resources

About